63.40p-0.60 (-0.94 %)03 Dec 2020, 13:23
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.

Ekf Diagnostics Holdings PLC Market & Company News

02.12.2020 07:00 Genomic testing service launch and Change of nameRNS
26.11.2020 07:01 Holding(s) in CompanyRNS
26.11.2020 07:00 Sale of shares in Renalytix AI plcRNS
24.11.2020 07:00 Update on strategic investment in Trellus HealthRNS
09.11.2020 07:00 Trading updateRNS
28.10.2020 14:15 Re-issued: EKF marketing & distribution agreementRNS
28.10.2020 07:00 EKF & Kantaro partner to market antibody testingRNS
26.10.2020 07:00 Dividend confirmationRNS
02.10.2020 06:00 Trading updateRNS
01.10.2020 06:00 Exercise of Options and Total Voting RightsRNS
14.09.2020 17:14 Dividend Timetable AmendmentRNS
14.09.2020 06:00 Half-year ReportRNS
10.09.2020 11:00 Notice of ResultsRNS
20.08.2020 06:00 Strategic investmentRNS
05.08.2020 06:01 Executive Performance BonusRNS
05.08.2020 06:00 Supply contract for COVID19 sample collection kitsRNS
14.07.2020 06:00 Update on trading and COVID-19 related contractRNS
24.06.2020 15:40 Second Price Monitoring ExtnRNS
24.06.2020 15:35 Price Monitoring ExtensionRNS
12.06.2020 15:41 Second Price Monitoring ExtnRNS
12.06.2020 15:35 Price Monitoring ExtensionRNS
10.06.2020 16:43 Results of AGMRNS
08.06.2020 15:41 Second Price Monitoring ExtnRNS
08.06.2020 15:36 Price Monitoring ExtensionRNS
15.05.2020 06:00 Update on trading and COVID-19 related contractRNS
07.05.2020 06:00 Posting of Annual Report & Accounts &Notice of AGMRNS
06.05.2020 10:30 Exercise of options and Total Voting RightsRNS
05.05.2020 15:41 Second Price Monitoring ExtnRNS
05.05.2020 15:36 Price Monitoring ExtensionRNS
05.05.2020 06:00 Distribution Agreement for Quo-Test HbA1c AnalyzerRNS
29.04.2020 06:00 UK contract for COVID-19 sample collection kitsRNS
28.04.2020 06:00 COVID-19 related manufacturing capacity updateRNS
27.04.2020 06:00 Update on COVID-19 related manufacturing contractRNS
07.04.2020 06:00 Final ResultsRNS
24.03.2020 07:00 Detailed trading review including COVID-19 updateRNS
04.03.2020 07:00 Notice of ResultsRNS
24.02.2020 13:56 Holding(s) in CompanyRNS
29.01.2020 07:00 Trading updateRNS
06.11.2019 12:14 Trading update and performance bonusesRNS
10.09.2019 06:00 Half-year ReportRNS
10.09.2019 06:00 Preferred Partner Arrangement with Mount SinaiRNS
21.08.2019 06:00 Notice of ResultsRNS
08.08.2019 15:40 Second Price Monitoring ExtnRNS
08.08.2019 15:35 Price Monitoring ExtensionRNS
15.07.2019 06:00 Trading updateRNS
11.06.2019 13:15 Cancellation of share optionsRNS
07.06.2019 15:30 Holding(s) in CompanyRNS
28.05.2019 06:00 Director/PDMR ShareholdingRNS
02.05.2019 10:21 Result of AGMRNS
26.04.2019 17:20 Acquisition of further interest in Renalytix AIRNS
25.04.2019 06:00 Posting of AR & Accounts and Notice of AGMRNS
13.03.2019 07:00 Final ResultsRNS
08.03.2019 07:00 Notice of ResultsRNS
20.02.2019 07:00 US FDA approval for Quo-Test analyserRNS
22.01.2019 07:00 Update on McKesson US distribution agreementRNS
21.01.2019 07:00 Clarification re. lock-up restrictionsRNS
16.01.2019 07:00 Trading updateRNS
20.12.2018 07:00 Update regarding planned change of NOMADRNS
19.12.2018 16:56 PDMR dealingRNS
07.12.2018 15:15 Purchase of own shares and PDMR DealingRNS
30.11.2018 14:35 Total Voting RightsRNS
22.11.2018 17:13 Purchase of own shares and PDMR DealingRNS
21.11.2018 14:08 Purchase of own shares and PDMR DealingRNS
20.11.2018 17:18 Purchase of own shares and PDMR DealingRNS
14.11.2018 14:20 Share Buy-BackRNS
09.11.2018 13:48 Director/PDMR ShareholdingRNS
06.11.2018 07:00 RENX Admission to AIM and First Day of DealingsRNS
02.11.2018 08:00 Schedule 1 update - Renalytix AI plcRNS
01.11.2018 17:30 Update regarding AIM admission of RenalytixAIRNS
31.10.2018 18:00 Result of RO by RenalytixAI & Fundraising UpdateRNS
23.10.2018 13:00 Schedule One Update - Renalytix AI plcRNS
23.10.2018 10:01 Update to distribution timetableRNS
22.10.2018 16:23 Approval of distribution of shares in RenalytixAIRNS
19.10.2018 11:10 Result of General MeetingRNS
19.10.2018 10:00 Schedule One - Renalytix AI plcRNS
11.10.2018 17:03 Launch of Restricted Offer by Renalytix AI plcRNS
11.10.2018 16:21 Fundraising and AIM admission of Renalytix AI plcRNS
11.10.2018 15:01 Fundraising and AIM admission of Renalytix AI plcRNS
27.09.2018 09:15 Notice of GMRNS
19.09.2018 06:00 Half-year ReportRNS
17.09.2018 11:21 Notice of ResultsRNS
31.08.2018 13:00 Update regarding proposed IPO of Renalytix AIRNS
16.08.2018 06:00 Holding(s) in CompanyRNS
09.08.2018 06:14 Trading updateRNS
09.08.2018 06:00 DiaSpect Tm McKesson US distribution agreementRNS
08.08.2018 15:09 Holding(s) in CompanyRNS
24.07.2018 07:45 US distribution agreement for diabetes assay kitRNS
19.07.2018 06:00 Manufacturing partnership with Oragenics, Inc.RNS
04.07.2018 14:15 Exploring funding options for Renalytix AIRNS
07.06.2018 13:30 Holding(s) in CompanyRNS
01.06.2018 09:00 Update regarding Renalytix AI PLCRNS
31.05.2018 06:00 Licence and collaboration agreement signedRNS
08.05.2018 14:10 Result of AGMRNS
18.04.2018 09:36 Posting of AR and Accounts & Notice of AGMRNS
09.04.2018 07:25 US FDA approval for Diaspect TmRNS
21.03.2018 14:18 Holding(s) in CompanyRNS
14.03.2018 07:00 Final ResultsRNS
21.02.2018 07:00 Notice of ResultsRNS
11.01.2018 07:00 Trading updateRNS
29.12.2017 07:00 Total Voting RightsRNS
Showing 1 to 100 of 1,000